InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Henrik Krook, 管理人员. Officer active across 1 company, notably Egetis Therapeutics AB (publ). Cumulatively, 4 disclosures have been published. History available since 26 November 2025. The latest transaction was disclosed on 11 May 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
Companies and markets linked to Henrik Krook
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
264,880 股@ SEK 6.500.0064% mcap94.6% 占其流量AktieISIN SE0003815604FI:csv-4f6c60d76c6f9c961f8e
264,880 股0AktieISIN SE0003815604FI:csv-5062421e5700a2577d48
264,880 股0AktieISIN SE0003815604FI:A003Y615-1
25,000 股@ €0.35720.0004% mcap100.0% 占其流量AktieISIN SE0003815604FI:A003U240-1
4 条申报中的 4 条
About Henrik Krook
Henrik Krook is a member of the administration of Egetis Therapeutics AB (publ). He is involved in strategic decision-making and oversight of the company's operations.
